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Abstract 
We report a 50-year-old male with pseudocysts in the pancreatic tail associated with 
chronic pancreatitis successfully treated by transpapillary cyst drainage. He had 
previously undergone ultrasonography-guided percutaneous cyst drainage for a 
pancreatic pseudocyst in our hospital. He was readmitted due to abdominal pain and 
fever. Computed tomography showed recurrence of a pseudocyst in the pancreatic tail 
measuring 5 cm in diameter. Since conservative treatment failed, endoscopic retrograde 
pancreatography was performed. There was communication between the pseudocyst 
and the main pancreatic duct, and pancreatic duct stenosis proximal to the pseudocyst. 
First, transpapillary pancreatic duct drainage was performed using a plastic stent, but the 
pseudocyst did not decrease in size and became infected. After removal of the stent, a 
pigtail type nasocystic catheter was placed in the pseudocyst via the pancreatic duct. 
The pseudocyst infection immediately disappeared, and the pseudocyst gradually 
decreased and disappeared. After removal of the nasocystic catheter, no recurrence was 
observed. As transpapillary drainage of pancreatic pseudocyst, cyst drainage and 
pancreatic duct drainage have been reported. In our patient with pseudocyst in the  
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pancreatic tail, duct drainage was ineffective and the pseudocyst was infected, whereas 
cyst drainage was very effective. We considered that cyst drainage by a nasocystic 
catheter was the first-line therapy as the transpapillary drainage of the pancreatic 
pseudocyst. 
 
Introduction 
Pancreatic cysts are classified into pseudocysts, cystic tumors and true cysts. The 
majority of pancreatic cysts are pseudocysts. Most cystic tumors consist of serous cystic 
tumors, mucinous cystic neoplasms, intraductal papillary mucinous neoplasms and solid 
pseudopapillary tumors. Pancreatic cystic tumors represent a wide clinicopathological 
spectrum from benign to malignant. Mucinous cystic neoplasms and intraductal papillary 
mucinous neoplasms are precursor lesions of pancreatic adenocarcinoma [1]. 
Symptomatic cysts, increasing age and multilocular cysts (with a solid component and 
thick walls) are predictors of malignancy [2], whereas pseudocysts occur following acute 
pancreatitis, chronic pancreatitis or secondary to pancreatic trauma and have no 
malignant potential. Pseudocysts can resolve spontaneously or cause persistent symptoms 
and complications. The complications of pseudocysts are infection, obstructive jaundice, 
intracystic bleeding, hematoma and rupture. A diameter of >6 cm and growth of the 
pseudocysts are important predictors of the need for treatment [3]. 
For the treatment of pseudocysts, endoscopic drainage instead of surgical or 
percutaneous drainage is frequently performed. As endoscopic drainage, transpapillary 
drainage and transmural drainage, such as cystogastrostomy and cystoduodenostomy, 
have been reported. An appropriate drainage is selected based on anatomical 
characteristics. Yet recently, transpapillary drainage without needle puncture has been 
recommended because of low complication rate [4]. As transpapillary drainage, cyst 
drainage, in which the stent is inserted into the cyst, and duct drainage, in which the stent 
is placed in the pancreatic duct, have been reported, but their indications have not yet 
been established. As stents, the endoprosthesis is generally used, but the nasocystic 
catheter is also used in some cases [5]. 
We report a patient with a pseudocyst in the pancreatic tail successfully treated by 
transpapillary cyst drainage with a nasocystic catheter. 
Case Report 
A 50-year-old male with a 25-year history of alcohol abuse was admitted to our hospital due to 
epigastric pain and fever. He had undergone ultrasonography (US)-guided percutaneous cyst drainage 
for a pseudocyst associated with chronic pancreatitis 3 months earlier, and the pseudocyst had 
disappeared. His temperature was 39.2°C, and tenderness was present in the left hypochondrium. Blood 
data indicated an increased value in AST 65 IU/l, γ-GTP 339 IU/l, ALP 440 IU/l, CRP 22.6 mg/dl, and 
elastase 1 1,164 ng/ml. US and computed tomography (CT) showed a large pseudocyst measuring 5 cm 
in diameter and some small cysts in the pancreatic tail (fig. 1). A heterogeneous echo was observed in 
US imaging. The pancreas was generally atrophic, and there were no pancreatic stones. Magnetic 
resonance cholangiopancreatography revealed a main pancreatic duct stenosis in the pancreatic body 
and cysts in the pancreatic tail. 
Recurrence of the pseudocyst secondary to alcohol was diagnosed, and conservative treatment was 
performed for about 3 weeks. The abdominal pain and fever improved, and blood data normalized, but 
the pseudocyst did not decrease in size. Endoscopic retrograde pancreatography showed 
communication between the pseudocyst and the main pancreatic duct, and a main pancreatic duct 
stenosis proximal to the pseudocyst (fig. 2). First, a 5-Fr-sized plastic stent (Zimmon pancreatic stent;  
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Wilson-Cook Medical Inc., Winston-Salem, N.C., USA) was placed beyond the stenosis. Transpapillary 
pancreatic duct drainage was performed for 2 weeks, but the pseudocyst increased, and infection 
occurred. After removal of the stent, a 5-Fr-sized pigtail type nasocystic catheter (Flexima ENBD 
catheter; Microvasive Endoscopy, Boston Scientific Corp., Natic, Mass., USA) was placed in the 
pseudocyst via the pancreatic duct (fig. 3). The drainage fluid from the pseudocyst was sticky debris. We 
irrigated the cystic cavity with saline solution from the endoscopic nasocystic catheter for 1 week. 
After nasocystic drainage the symptoms improved immediately, and blood data were normal after 
1 week. Since CT performed after 2 weeks revealed a marked reduction in the size of the pseudocyst, the 
catheter was kept for 2 weeks and then removed. After the removal, the cyst disappeared. Neither 
recurrence of pseudocysts nor symptoms have been observed after treatment. 
Discussion 
Pancreatic pseudocysts complicate mainly acute and chronic pancreatitis. 
Approximately 20–60% of pseudocystsregress spontaneously. The majority regress 
within 6–12 weeks. Symptomatic pseudocysts and pseudocysts without evidence of 
regression for longer than 6 weeks are generally an indication for drainage therapy. We 
abided by this indication. However, this case was not in this indication, as the patient had 
undergone US-guided percutaneous cyst drainage for the pseudocyst 3 months earlier 
and the pseudocyst had recurred. We considered that this pseudocyst might not have 
regressed. Therefore we performed drainage therapy. 
Previously, surgical drainage was the only effective treatment for pancreatic 
pseudocysts, but several authors have reported significant procedural morbidity and 
mortality [6, 7]. Subsequently, CT- or US-guided percutaneous drainage developed and 
has been reported to be useful. However, the problems of this drainage method were a 
high recurrence rate and a high incidence of fistula formation [8, 9]. 
Since the first endoscopic treatment for pseudocysts in 1975 [10], many studies have 
been reported with advances of endoscopes, devices and technique. As an endoscopic 
treatment, there are two approaches, i.e., transpapillary drainage and transmural drainage 
such as cystogastrostomy and cystoduodenostomy, and an appropriate method is selected 
based on the anatomical characteristics of the pseudocyst. Transpapillary drainage can be 
performed if the pseudocyst communicates with the main pancreatic duct, and 
transmural drainage if the pseudocyst is in direct contact with the gastric or duodenal 
wall. Previously, transmural drainage was performed irrespective of the presence or 
absence of cyst-duct communication, and a high pseudocyst disappearance rate (90–98%) 
was reported. However, this technique is difficult, and the incidence of complications 
such as hemorrhage and perforation was relatively high [11]. Binmoeller et al. [4] 
performed endoscopic drainage in 53 patients with pseudocysts, of whom 33 underwent 
transpapillary drainage and the other 20 transmural drainage. The technical success rates 
were 100 and 80% for transpapillary and transmural drainage, respectively, and the 
pseudocyst disappearance rate was 94% for both methods. They reported that 
transpapillary drainage is less invasive and safe, recommending this method as the first 
choice. Based on previous reports, communication between the pseudocyst and main 
pancreatic duct is observed in 55–69% of patients [4, 7, 12, 13], and thus transpapillary 
drainage is indicated in a large proportion of patients with pseudocysts. 
As transpapillary drainage, cyst drainage in which the stent is placed directly in the 
pseudocyst, and duct drainage in which the stent is placed in the main pancreatic duct 
near the cyst, have been reported. Barthet et al. [5] performed transpapillary drainage in 
30 patients, of whom 12 could be treated by cyst drainage but the other 18 could not be 
treated by cyst drainage and underwent duct drainage. Since the pseudocyst  
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disappearance rate was higher for cyst drainage (92%) than duct drainage (67%), they 
recommended that cyst drainage should be performed whenever possible. Catalano et al. 
[14] performed duct drainage beyond the main pancreatic duct stenosis proximal to the 
pseudocyst and observed cyst disappearance in 88%, concluding that duct drainage 
should be selected in the presence of main pancreatic duct stenosis. Thus, there is no 
consensus concerning the placement site of the stent. 
The location of pseudocysts affects the effect of transpapillary cyst drainage. Previous 
studies have reported a lower success rate in the pancreatic tail (60%) than in the 
pancreatic head and body (80%) [5, 14]. This may be due to technical difficulties in the 
area apart from the papilla. 
Our patient showed communication between the pseudocyst and the main pancreatic 
duct accompanied by pancreatic duct stenosis. Therefore duct drainage was first 
performed, but the pseudocyst did not decrease in size. Next, the drainage method was 
changed to cyst drainage using a nasocystic catheter, which resulted in disappearance of 
pseudocyst. Barthet et al. [5] used a nasocystic catheter in cases with heterogeneous 
pseudocyst, i.e. with associated debris and necrotic tissue or pancreatic abscesses, to allow 
irrigation of the cystic cavity with saline solution. In our case, heterogeneous echo was 
observed in US imaging. The drainage fluid from the pseudocyst was sticky debris. The 
cyst content was one of the reasons why the pseudocyst did not regress with pancreatic 
stent insertion and became infected. Duct drainage is technically easier than cyst 
drainage, but we recommend cyst drainage by a nasocystic catheter as the first choice, 
especially when the cyst content is heterogeneous. 
As complications of transpapillary drainage, acute pancreatitis, infection of the 
pseudocysts and pseudocyst biliary fistula have been reported. Kobayashi et al. [15] 
reported a case of chronic pancreatitis associated with infected pseudocysts after 
endoscopic pancreatic stenting. We should take this complication into consideration 
when performing transpapillary drainage, especially in cases of duct drainage with 
pancreatic stent. 
We report a patient with a pseudocyst in the pancreatic tail successfully treated by 
transpapillary cyst drainage with a nasocystic catheter for a short period of time. This case 
may provide important information for the selection of two transpapillary drainage 
techniques in the future. 
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Fig. 1. CT showed a large pseudocyst measuring 5 cm in diameter and some small cysts in the 
pancreatic tail. 
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Fig. 2. Endoscopic retrograde pancreatography showed communication between the pseudocyst 
(arrows) and the main pancreatic duct, and a main pancreatic duct stenosis (arrowhead) proximal to the 
pseudocyst. 
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Fig. 3. A pigtail type nasocystic catheter was placed in the pseudocyst via the pancreatic duct. 
 
  
Case Rep Gastroenterol 2008;2:390–397 
DOI: 10.1159/000163377 
Published online: November 11, 2008  © 2008 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
397
References 
1  Singh M, Maitra A: Precursor lesions of pancreatic cancer: molecular pathology 
and clinical implications. Pancreatology 2007;7:9–19. 
2  Garcea G, Ong SL, Rajesh A, Neal CP, Pollard CA, Berry DP, Dennison AR: 
Cystic lesions of the pancreas. A diagnostic and management dilemma. 
Pancreatology 2008;8:236–251. 
3  Lu X, Uchida E, Yokoyama S, Nakamura Y, Amimoto T, Tajiri T: Features and 
choice of treatment of acute and chronic pancreatic pseudocysts – with special 
reference to invasive intervention. Pancreatology 2008;8:30–35. 
4  Binmoeller KF, Seifert H, Walter A, Soehendra N: Transpapillary and transmural 
drainage of pancreatic peudocyst. Gastrointest Endosc 1995;42:219–224. 
5  Barthet M, Sahel J, Bodiou-Bertei C, Bernard JP: Endoscopic transpapillary 
drainage of pancreatic pseudocysts. Gastrointest Endosc 1995;42:208–213. 
6  Martin EW Jr, Catalano P, Cooperman M, Hecht C, Carey LC: Surgical 
decision-making in the treatment of pancreatic pseudocysts. Internal versus 
external drainage. Am J Surg 1979;138:821–824. 
7  Barkin JS, Hyder SA: Changing concepts in the management of pancreatic 
pseudocysts. Gastrointest Endosc 1989;35:62–64. 
8  MacErlean DP, Bryan PJ, Murphy JJ: Pancreatic pseudocyst: management by 
ultrasonographically guided aspiration. Gastrointest Radiol 1980;5:255–257. 
9  Adams DB, Harvey TS, Anderson MC: Percutaneous catheter drainage of 
pancreatic pseudocysts. Am Surg 1991;57:29–33. 
10  Rogers BHG, Cicurel NJ, Seed RW: Transgastric needle aspiration of pancreatic 
pseudocyst through an endoscope. Gastrointest Endosc 1975;21:133–134. 
11  Cremer M, Deviere J, Engelholm L: Endoscopic management of cysts and 
pseudocysts in chronic pancreatitis: long-term follow-up after 7 years of 
experience. Gastrointest Endosc 1989;35:1–9. 
12  Sahel J, Bastid C, Pellat B, Schurgers P, Sarles H: Endoscopic cystoduodenostomy 
of cysts of chronic calcifying pancreatitis: a report of 20 cases. Pancreas 
1987;2:447–453. 
13  Liguory C, Lefebvre JF, Vitale GC: Endoscopic drainage of pancreatic 
pseudocysts. Can J Gastroenterol 1990;4:568–571. 
14  Catalano MF, Geenen JE, Schmalz MJ, Johnson GK, Dean RS, Hogan WJ: 
Treatment of pancreatic pseudocysts with ductal communication by 
transpapillary pancreatic duct endoprosthesis. Gastrointest Endosc 1995;42:214–
218. 
15  Kobayashi S, Ohara H, Nakazawa T, Sano H, Ando T, Aoki S, Okamoto T, 
Takada H, Hayashi K, Tanaka H, Kitajima Y, Mizuno S, Joh T: A case of chronic 
pancreatitis associated with infected psedocyst after endoscopic pancreatic 
stenting. Suizo 2006;21:89–94. 
 